A previously healthy 37-year-old woman was admit-ted to our Clinic in June 2007 for acute left homony-mous hemianopsia. Brain Computed Tomography (CT) scan revealed a right temporal-occipital lesion, with mass effect on the surrounding structures. Brain Magnetic Resonance Imaging (MRI) disclosed a large tumefactive right parietal-temporal-occipital lesion, hyper-intense on Fluid Attenuated Inversion Recovery (FLAIR) sequences, with mild peripheral gadolinium enhancement (Figure 1). The haematological and immunological panels were normal, and no infection or tumour markers were found. The patient underwent a stereotactic biopsy of the lesion to exclude a primary brain tumour. Histology showed perivascular lympho-cytic cuffs and demyelination...
Introduction: Tumefactive multiple sclerosis is a demyelinating disorder that appears tumor-like on ...
peer reviewedA 19-y old sportsman was admitted because he complained of ascending paresthesia since ...
r. KS has been supported by a Higher Education Funding Council for England (HEFCE) Clinical Senior ...
Multiple sclerosis (MS) is an autoimmune condition in which the immune system attacks the central ne...
were female; age ranged from 32 to 57 years, the duration of symptoms varied from 3 days to 3 years....
A 26-year-old woman with history of diabetes insipidus and hypothyroidism presented for evaluation o...
Copyright © 2012 Hossein Kalanie et al. This is an open access article distributed under the Creativ...
SUMMARY A 21 year old woman with subacute onset of moderate left hemiparesis showed on CT scanning a...
The patient is a 25 year old woman who was in excellent health until 4 days prior to admission when ...
demyelination refractory to corticosteroids and plasma exchange CASE HISTORY A 38-year-old woman wit...
Distinguishing between tumefactive demyelinating lesions (TDLs) and brain tumors in multiple scleros...
Atypical imaging features of multiple sclerosis lesions include size > 2 cm, mass effect, oedema and...
Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system, characterised by f...
AbstractTumefactive demyelinating lesions or tumefactive multiple sclerosis (TMS) constitute a uniqu...
Tumefactive demyelinating lesion, a variant of multiple sclerosis, is a solitary large demyelinating...
Introduction: Tumefactive multiple sclerosis is a demyelinating disorder that appears tumor-like on ...
peer reviewedA 19-y old sportsman was admitted because he complained of ascending paresthesia since ...
r. KS has been supported by a Higher Education Funding Council for England (HEFCE) Clinical Senior ...
Multiple sclerosis (MS) is an autoimmune condition in which the immune system attacks the central ne...
were female; age ranged from 32 to 57 years, the duration of symptoms varied from 3 days to 3 years....
A 26-year-old woman with history of diabetes insipidus and hypothyroidism presented for evaluation o...
Copyright © 2012 Hossein Kalanie et al. This is an open access article distributed under the Creativ...
SUMMARY A 21 year old woman with subacute onset of moderate left hemiparesis showed on CT scanning a...
The patient is a 25 year old woman who was in excellent health until 4 days prior to admission when ...
demyelination refractory to corticosteroids and plasma exchange CASE HISTORY A 38-year-old woman wit...
Distinguishing between tumefactive demyelinating lesions (TDLs) and brain tumors in multiple scleros...
Atypical imaging features of multiple sclerosis lesions include size > 2 cm, mass effect, oedema and...
Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system, characterised by f...
AbstractTumefactive demyelinating lesions or tumefactive multiple sclerosis (TMS) constitute a uniqu...
Tumefactive demyelinating lesion, a variant of multiple sclerosis, is a solitary large demyelinating...
Introduction: Tumefactive multiple sclerosis is a demyelinating disorder that appears tumor-like on ...
peer reviewedA 19-y old sportsman was admitted because he complained of ascending paresthesia since ...
r. KS has been supported by a Higher Education Funding Council for England (HEFCE) Clinical Senior ...